C-reactive protein point-of-care testing for safely reducing antibiotics for acute exacerbations of chronic obstructive pulmonary disease: the PACE RCT
Health Technology Assessment2020Vol. 24(15), pp. 1–108
Citations Over TimeTop 10% of 2020 papers
Nick Francis, David Gillespie, Patrick White, Janine Bates, Rachel Lowe, Bernadette Sewell, Rhiannon Phillips, Helen Stanton, Nigel Kirby, Mandy Wootton, Emma Thomas‐Jones, Kerenza Hood, Carl Llor, Jochen Cals, Hasse Melbye, Gurudutt Naik, Micaela Gal, Deborah Fitzsimmons, M Fasihul Alam, Evgenia Riga, Ann Cochrane, Christopher Butler
Abstract
This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 24, No. 15. See the NIHR Journals Library website for further project information.
Related Papers
- → Prevalence and underdiagnosis of COPD by disease severity and the attributable fraction of smoking(2005)278 cited
- → COPD in Nonsmokers: Reports from the Tunisian Population-Based Burden of Obstructive Lung Disease Study(2016)55 cited
- → Dyspnoea and symptom burden in mild–moderate COPD: the Canadian Cohort Obstructive Lung Disease Study(2021)17 cited
- → Die Prävalenz der COPD in Österreich – die erwartete Entwicklung bis 2020(2007)14 cited
- → COPD in non-smokers: Report from the Tunisian burden of obstructive lung disease study(2015)